ArticleFrontiers in pharmacology2024

A real-world pharmacovigilance analysis for transthyretin inhibitors: findings from the FDA adverse event reporting database.

Yuan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.